Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00123188 · ClinicalTrials.gov registry record · NA
Ultrasound and Endometrial Hyperplasia
A NA study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00123188 is a NA study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 36 participants.
The verdict
NCT00123188, a NA study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.
Interventions
- PROCEDURE Ultrasound and Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2005-04 |
| Est. Completion | 2009-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00123188
The ClinicalTrials.gov registry entry for NCT00123188 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound and Biopsy is the first listed.
NCT00123188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00123188 about?
NCT00123188 is a clinical study titled "Ultrasound and Endometrial Hyperplasia". The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.
What is the current status of trial NCT00123188?
This trial is currently terminated. It is a NA study. The enrollment target is 36 participants. The study started on 2005-04. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00123188?
The interventions under investigation include: Ultrasound and Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00123188?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.